PathAI Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- PathAI's estimated revenue is currently $16.7M per year.
- PathAI received $11.0M in venture funding in November 2017.
- PathAI's estimated revenue per employee is $144310
- PathAI's total funding is $75M.
- PathAI has 116 Employees.
- PathAI grew their employee count by 84% last year.
- PathAI currently has 12 job openings.
|Don O'Neill||VP of Engineering|
|Joseph Adu||Director of Technology|
|Jackson Wilkinson||Vice President of Product|
|Leticia Booth||Director of Quality and Regulatory Compliance|
|Ilan Wapinski||Senior Director of Scientific Programs|
|Tiffany Freitas||Chief Business Officer|
|David Wigder||Director of Product|
|Jennifer Kerner||Director of Pathology|
|Hunter Elliott||Director of Machine Learning Research|
|Dayong Wang||VP Machine Learning|
What Is PathAI?
PathAI's mission is to advance medicine with intelligent pathology. PathAI's platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses. Research and Drug Development Solutions PathAI's deep-learning solutions drive discovery and predictive diagnostics in drug-development. PathAI's technology accelerates R&D efforts and brings standardization to all phases of the drug development pipeline. Clinical Solutions PathAI is developing clinical decision support tools to improve the clinical workflow and bring increased efficiency, standardization, and clinical insights to diagnostic pathology. Global Health Solutions PathAI is working towards improving health around the globe, by building machine learning applications to provide pathologic diagnoses at a low cost in developing nations. PathAI's goal is to make an enduring impact on patient care by helping hundreds of millions of people receive accurate diagnoses and effective therapies.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Philips and PathAI group as much as enhance breast most cancers analysis utilizing synthetic intelligence expertise in 'huge information' pathology analysis.
PathAI, a startup that employs machine learning techniques to improve diagnostic accuracy, today announced that it's raised $60 million in ...
With a clinical version of PathAI's computer vision-based pathology detection service still at least one year from coming to market, the ...
|2017-11-06||$11.0M||A||General Catalyst Partners||Article|